HK1215571A1 - 二鹽酸科比思特 - Google Patents
二鹽酸科比思特Info
- Publication number
- HK1215571A1 HK1215571A1 HK16103508.1A HK16103508A HK1215571A1 HK 1215571 A1 HK1215571 A1 HK 1215571A1 HK 16103508 A HK16103508 A HK 16103508A HK 1215571 A1 HK1215571 A1 HK 1215571A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- dichlohydrate
- cobicostat
- salt
- dichlohydrate salt
- cobicostat dichlohydrate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261745964P | 2012-12-26 | 2012-12-26 | |
US201361783325P | 2013-03-14 | 2013-03-14 | |
PCT/US2013/077394 WO2014105777A1 (en) | 2012-12-26 | 2013-12-23 | Cobicostat dichlohydrate salt |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1215571A1 true HK1215571A1 (zh) | 2016-09-02 |
Family
ID=49950084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16103508.1A HK1215571A1 (zh) | 2012-12-26 | 2016-03-24 | 二鹽酸科比思特 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20160200716A1 (zh) |
EP (1) | EP2938603A1 (zh) |
JP (1) | JP2016504364A (zh) |
HK (1) | HK1215571A1 (zh) |
IL (1) | IL239281A0 (zh) |
WO (1) | WO2014105777A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014356067A1 (en) * | 2013-11-29 | 2016-06-16 | Mylan Laboratories Ltd. | Amorphous cobicistat solid dispersion |
CN105732538B (zh) * | 2014-12-09 | 2018-04-13 | 杭州普晒医药科技有限公司 | 可比司他帕莫酸盐及其制备方法、药物组合物和用途 |
WO2016132378A2 (en) * | 2015-02-18 | 2016-08-25 | Msn Laboratories Private Limited | Novel process for the preparation of 1,3-thiazol-5-ylmethyl [(2r,5r)-5-{[(2s)-2- [(methyl{[2-(propan-2-yl)- 1,3-thiazol-4-yl] methyl} carbamoyl) amino] -4-(morpholin-4-yl)butanoyl]amino}-1,6-diphenylhexan-2-yl] carbamate |
CN107513046B (zh) * | 2016-06-15 | 2019-12-13 | 江苏欧信制药有限公司 | 一种可比司他的合成方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2049506B2 (en) * | 2006-07-07 | 2024-05-08 | Gilead Sciences, Inc. | Modulators of pharmacokinetic properties of therapeutics |
LT2487166T (lt) | 2007-02-23 | 2016-11-10 | Gilead Sciences, Inc. | Terapinių agentų farmakokinetinių savybių moduliatoriai |
CA2710679A1 (en) * | 2008-01-04 | 2009-07-16 | Gilead Sciences, Inc. | Inhibitors of cytochrome p450 |
SG190618A1 (en) * | 2008-05-02 | 2013-06-28 | Gilead Sciences Inc | The use of solid carrier particles to improve the processability of a pharmaceutical agent |
UA108738C2 (uk) * | 2009-04-03 | 2015-06-10 | Спосіб одержання інгібітора цитохром р450 монооксигенази та залучені проміжні сполуки | |
EP2705027B1 (en) | 2011-05-02 | 2015-06-03 | Gilead Sciences, Inc. | Amorphous solid salts of Cobicistat (GS-9350) |
-
2013
- 2013-12-23 WO PCT/US2013/077394 patent/WO2014105777A1/en active Application Filing
- 2013-12-23 JP JP2015550713A patent/JP2016504364A/ja active Pending
- 2013-12-23 US US14/654,202 patent/US20160200716A1/en not_active Abandoned
- 2013-12-23 EP EP13819171.3A patent/EP2938603A1/en not_active Withdrawn
-
2015
- 2015-06-08 IL IL239281A patent/IL239281A0/en unknown
-
2016
- 2016-03-24 HK HK16103508.1A patent/HK1215571A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP2938603A1 (en) | 2015-11-04 |
WO2014105777A1 (en) | 2014-07-03 |
US20160200716A1 (en) | 2016-07-14 |
WO2014105777A8 (en) | 2014-08-07 |
JP2016504364A (ja) | 2016-02-12 |
IL239281A0 (en) | 2015-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1199840A1 (zh) | 降伊波加因碱鹽非溶劑化物 | |
HK1201200A1 (zh) | 取代的吡咯烷- -甲酰胺 | |
DK3327112T3 (en) | Agse-deficient stamme | |
HK1200830A1 (zh) | 取代的吡咯烷- -甲酰胺 | |
EP2754580A4 (en) | DUMP TRUCK | |
DK2830816T3 (en) | Hidtil ukendt coatingkoncept | |
HK1206724A1 (zh) | 取代的苯並噻吩並嘧啶 | |
ZA201500408B (en) | Camsylate salt | |
EP2920142A4 (en) | MÉTHANOFULLERRÈNES | |
EP2934541A4 (en) | NORIBOGAINE SUBSTITUTE | |
PL2840907T3 (pl) | Substytut soli | |
HK1206022A1 (zh) | 取代的咪唑並噠嗪 | |
EP2812698A4 (en) | TIME RESOLVED FREIGHT AND DOUBLE ACCEPTOR | |
HK1215571A1 (zh) | 二鹽酸科比思特 | |
EP2920157A4 (en) | DI MACRO CYCLEN | |
EP2873363A4 (en) | DIOPSIMETER | |
EP2834250A4 (de) | Lithiumsilikate | |
PL2760822T3 (pl) | Sole desfezoterodyny | |
AU345893S (en) | Treehouse | |
GB201202382D0 (en) | Flexfix | |
GB201202208D0 (en) | Easomark | |
GB201201767D0 (en) | Pop-tops | |
GB201201668D0 (en) | LOCnlatch | |
GB201201023D0 (en) | Sharkbitze | |
GB201201085D0 (en) | Hit-a-pair |